Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study
DOI
Detection Principle
ImmunoAssay-Antibody
Target
IgG and IgA againt S1 protein
Testing Method Category
ELISA
Testing Method
IgA and IgG antibodies against S1 protein SARS-CoV-2 ELISA Euroimmun
Testing Method - Additional Info
Case study and clinical validity of serum antibodies against SARS-CoV2
Reported Performance
Sensitivity IgG: 0.976: Sensitivity IgA: 0.988;
Sample Size
11066 tested persons
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements